or Try an Advanced Search...

    Technical Analysis for RVPH - Reviva Pharmaceuticals Holdings, Inc.

    Grade Last Price % Change Price Change
    F 1.72 0.58% 0.01
    RVPH closed down 6.3 percent on Wednesday, May 15, 2024, on 1.38 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical RVPH trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.58%
    Lower Bollinger Band Walk Weakness 0.58%
    New 52 Week Low Weakness 0.58%
    Wide Bands Range Expansion 0.58%
    Lower Bollinger Band Touch Weakness 0.58%
    Oversold Stochastic Weakness 0.58%
    New Downtrend Bearish -5.75%
    Calm After Storm Range Contraction -5.75%
    NR7 Range Contraction -5.75%
    Lower Bollinger Band Walk Weakness -5.75%
    Older End-of-Day Signals for RVPH ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout 20 minutes ago
    Down 2 % about 2 hours ago
    Down 1% about 2 hours ago
    Lower Bollinger Band Support about 2 hours ago
    Fell Below Previous Day's Low about 24 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    RVPH Chart by TradingView
    Basic chart:

    Profile

    Reviva Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Its lead product candidate is RP5063 for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, as well as for treating pulmonary arterial hypertension and idiopathic pulmonary fibrosis. The company is based in Cupertino, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Drugs Inflammatory Diseases Schizophrenia Psychiatric Diagnosis Psychiatry Major Depressive Disorder Stage Pharmaceutical Idiopathic Pulmonary Fibrosis Pulmonary Arterial Hypertension Pulmonary Fibrosis Chloroarenes Bipolar Disorder Pulmonary Hypertension Treatment Of Schizophrenia Piperazines

    Is RVPH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 15 Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia
    May 14 Reviva Pharmaceuticals GAAP EPS of -$0.25
    May 14 Reviva Reports First Quarter 2024 Financial Results and Recent Business Highlights
    May 13 Reviva to Present New Preclinical Efficacy Data on Brilaroxazine in Idiopathic Pulmonary Fibrosis at 2024 ATS International Conference
    May 9 Reviva to Present New Non-Clinical Pharmacology Data on Brilaroxazine at the ASPET 2024 Annual Meeting
    Apr 25 RVPH: Full Year 2023 Results
    Apr 15 Reviva Pharmaceuticals FY Non-GAAP EPS of -$1.65 beats by $0.01
    Apr 15 Reviva reports FDA acceptance of 4-week RECOVER-2 study for its schizophrenia treatment
    Apr 15 Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia
    Apr 15 Reviva Reports Full Year 2023 Financial Results and Recent Business Highlights
    See more RVPH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 8.3
    52 Week Low 1.6
    Average Volume 298,302
    200-Day Moving Average 4.11
    50-Day Moving Average 3.13
    20-Day Moving Average 2.73
    10-Day Moving Average 2.42
    Average True Range 0.29
    RSI (14) 23.66
    ADX 28.95
    +DI 10.67
    -DI 38.03
    Chandelier Exit (Long, 3 ATRs) 2.56
    Chandelier Exit (Short, 3 ATRs) 2.46
    Upper Bollinger Bands 3.78
    Lower Bollinger Band 1.68
    Percent B (%b) 0.02
    BandWidth 77.05
    MACD Line -0.40
    MACD Signal Line -0.27
    MACD Histogram -0.1336
    Fundamentals Value
    Market Cap 47.74 Million
    Num Shares 27.9 Million
    EPS -1.68
    Price-to-Earnings (P/E) Ratio -1.02
    Price-to-Sales 0.00
    Price-to-Book 69.86
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.03
    Resistance 3 (R3) 2.02 1.92 1.97
    Resistance 2 (R2) 1.92 1.84 1.92 1.95
    Resistance 1 (R1) 1.81 1.79 1.76 1.82 1.94
    Pivot Point 1.71 1.71 1.68 1.71 1.71
    Support 1 (S1) 1.60 1.63 1.55 1.61 1.48
    Support 2 (S2) 1.50 1.58 1.50 1.47
    Support 3 (S3) 1.39 1.50 1.45
    Support 4 (S4) 1.40